Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
Crossref DOI link: https://doi.org/10.1007/s40291-017-0277-9
Published Online: 2017-04-27
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kotrova, Michaela
Trka, Jan
Kneba, Michael
Brüggemann, Monika http://orcid.org/0000-0001-5514-5010
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (AZV 16-32568A)
License valid from 2017-04-27